LLY

992.2

+2.54%↑

JNJ

225.55

+0.2%↑

ABBV

206.52

-0.05%↓

UNH

361.4

-2.18%↓

AZN

184.31

+1.95%↑

LLY

992.2

+2.54%↑

JNJ

225.55

+0.2%↑

ABBV

206.52

-0.05%↓

UNH

361.4

-2.18%↓

AZN

184.31

+1.95%↑

LLY

992.2

+2.54%↑

JNJ

225.55

+0.2%↑

ABBV

206.52

-0.05%↓

UNH

361.4

-2.18%↓

AZN

184.31

+1.95%↑

LLY

992.2

+2.54%↑

JNJ

225.55

+0.2%↑

ABBV

206.52

-0.05%↓

UNH

361.4

-2.18%↓

AZN

184.31

+1.95%↑

LLY

992.2

+2.54%↑

JNJ

225.55

+0.2%↑

ABBV

206.52

-0.05%↓

UNH

361.4

-2.18%↓

AZN

184.31

+1.95%↑

Home・Lista de Ações・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Fechado

SetorSaúde

469.14 1.68

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

459.78

Máximo

468.84

Indicadores-chave
By Trading Economics
Rendimento	-314M 1.7B
Vendas	-1.2B 11B
P/E Médio do Setor	25.772 49.8
EPS	5.44
Rendimento de Dividendos	0.38
Margem de lucro	15.048
Funcionários	125,000
EBITDA	-905M 2.3B

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+34.17% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	0.38% 2.25%
Próximos Ganhos	22 de jul. de 2026
Próxima data de dividendos	14 de jul. de 2026
Próxima data de ex-dividendo	12 de jun. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-24B 172B
Abertura anterior	467.46
Fecho anterior	469.14

Sentimento de Notícias

By Acuity

24%

76%

85 / 347 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

406.5 / 417.79 Suporte e Resistência

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de abr. de 2026, 13:56 UTC

Ganhos

Thermo Fisher Profit Up, Warns of Inflation from Iran War -- Update

23 de abr. de 2026, 10:28 UTC

Ganhos

Thermo Fisher Posts Higher 1Q Profit, Revenue

29 de jan. de 2026, 11:34 UTC

Ganhos

Thermo Fisher 4Q Profit Rises as Biopharma Spending Rebounds

29 de out. de 2025, 10:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 billion

23 de out. de 2025, 20:49 UTC

Ganhos

Correction to Thermo Fisher Article on Oct. 22

22 de out. de 2025, 10:28 UTC

Ganhos

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 de abr. de 2026, 10:01 UTC

Ganhos

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 de abr. de 2026, 10:01 UTC

Ganhos

Thermo Fisher: Well Positioned to Deliver Strong Year >TMO

23 de abr. de 2026, 10:00 UTC

Ganhos

Thermo Fisher 1Q Net $1.65B >TMO

23 de abr. de 2026, 10:00 UTC

Ganhos

Thermo Fisher 1Q Adj EPS $5.44 >TMO

23 de abr. de 2026, 10:00 UTC

Ganhos

Thermo Fisher 1Q EPS $4.43 >TMO

23 de abr. de 2026, 10:00 UTC

Ganhos

Thermo Fisher 1Q Rev $11.01B >TMO

24 de mar. de 2026, 12:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Completes Acquisition of Clario Holdings for $8.875 Billion >TMO

24 de mar. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific Completes Acquisition Of Clario Holdings, Inc. >TMO

29 de jan. de 2026, 11:01 UTC

Ganhos

Thermo Fisher 4Q Organic Revenue Rose 3% >TMO

29 de jan. de 2026, 11:00 UTC

Ganhos

Thermo Fisher: Entering 2026 From Position of Strength >TMO

29 de jan. de 2026, 11:00 UTC

Ganhos

Thermo Fisher 4Q Net $1.96B >TMO

29 de jan. de 2026, 11:00 UTC

Ganhos

Thermo Fisher 4Q Rev $12.22B >TMO

29 de jan. de 2026, 11:00 UTC

Ganhos

Thermo Fisher 4Q EPS $5.21 >TMO

29 de jan. de 2026, 11:00 UTC

Ganhos

Thermo Fisher 4Q Adj EPS $6.57 >TMO

29 de out. de 2025, 10:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher: Clario Provides Endpoint Data Solutions for Clinical Trials >TMO

29 de out. de 2025, 10:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher: Claro Deal Includes Potential Additional Earnout, Other Payments >TMO

29 de out. de 2025, 10:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher to Buy Clario From Group Led by Astorg and Nordic Cap, Novo Holding, Cinven >TMO

29 de out. de 2025, 10:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific to Pay $8.875 Billion at Closing for Clario Holdings >TMO

29 de out. de 2025, 10:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific to Acquire Clario Holdings >TMO

22 de out. de 2025, 10:01 UTC

Ganhos

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Rev $11.12B >TMO

22 de out. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 3Q Net $1.62B >TMO

Comparação entre Pares

Variação de preço

Thermo Fisher Scientific Inc Previsão

Preço-alvo

By TipRanks

34.17% parte superior

Previsão para 12 meses

Média 620.69 USD 34.17%

Máximo 685 USD

Mínimo 560 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

15 ratings

Comprar

Manter

Vender

Com base em 15 analistas que deram avaliações de ações para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

406.5 / 417.79Suporte e Resistência

Recent bearish events outweigh bullish events.

There is one bearish event.

All events are bearish.

Sentimento

By Acuity

85 / 347 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar